Many recent studies have described an emerged role of these death ligands (CD95L, TNF-α and TRAIL) in the enhanced production of various PICs; chemokines as well as TAPs that are linked with short survival and advanced tumor stages in various malignancies, including PDAC in an NFκB-dependent manner [22,27]. Here, TNFSF10 is linked to neoplasm.